The company is an online search business whose website helps patients with medical conditions to access information on clinical trials anywhere in the world.
The funding will enable the company, headquartered in London, to develop its platform for patients, physicians and pharmaceuticals companies and to expand its services to multiple regions around the world, in native languages, it said.
Amadeus Partner, Alex van Someren, said, “I was impressed from the outset by the importance of what TrialReach does in quickly connecting patients with treatments which could help them. Even better, the company is led by a team with real experience in building successful technology businesses. I’m genuinely excited about the potential for TrialReach to improve people’s lives, save trial sponsors time and money, and build a global business.”
Amadeus Capital Partners has some £470m under management. Since its inception in 1997, the firm has backed nearly 70 companies in industries that include communications and networking hardware and software, cleantech, medtech, computer hardware and software, media, and e-commerce.
Copyright © 2011 AltAssets